With the increase in ferritin levels, the blood glucose and insulin levels gradually increase, further aggravating insulin resistance, which is a potential mediating factor in the relationship between serum ferritin and NAFLD, and obesity, which is one of the risk factors for NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.